Karisbamat

Karisbamat
Klinički podaci
AHFS/Drugs.com Monografija
Identifikatori
CAS broj 194085-75-1
ATC kod N03AX19
PubChem[1][2] 9942577
ChemSpider[3] 8118189
UNII P7725I9V3Z DaY
Hemijski podaci
Formula C9H10ClNO3 
Mol. masa 215,634
SMILES eMolekuli & PubHem
InChI
InChI=1S/C9H10ClNO3/c10-7-4-2-1-3-6(7)8(12)5-14-9(11)13/h1-4,8,12H,5H2,(H2,11,13)/t8-/m0/s1
Key: OLBWFRRUHYQABZ-QMMMGPOBSA-N DaY
Farmakoinformacioni podaci
Trudnoća ?
Pravni status

Karisbamat je organsko jedinjenje, koje sadrži 9 atoma ugljenika i ima molekulsku masu od 215,634 Da.

Osobine

Osobina Vrednost
Broj akceptora vodonika 4
Broj donora vodonika 3
Broj rotacionih veza 4
Particioni koeficijent[4] (ALogP) 2,2
Rastvorljivost[5] (logS, log(mol/L)) -1,8
Polarna površina[6] (PSA, Å2) 73,5

Reference

  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o. 
  5. Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573. 
  6. Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286. 

Literatura

  • Hardman JG, Limbird LE, Gilman AG. (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10 izd.). New York: McGraw-Hill. DOI:10.1036/0071422803. ISBN 0-07-135469-7. 
  • Thomas L. Lemke, David A. Williams, ur. (2007). Foye's Principles of Medicinal Chemistry (6 izd.). Baltimore: Lippincott Willams & Wilkins. ISBN 0-7817-6879-9. 

Spoljašnje veze

Portal Medicina
Portal Hemija
Karisbamat na Wikimedijinoj ostavi
  • Carisbamate
  • p
  • r
  • u
Agonist GABAA receptora
Drugi GABA agensi
Inhibitori karbonske anhidraze
Sulfonamid
Blokatori kanala
Prvenstveno natrijum
Prvenstveno kalcijum
Nepoznato/negrupisani
Otvarači kanala
Indirektni GABA agensi
Nepoznato/višestruki/
negrupisani
Emilkamat • Felbamat • Meprobamat • Karisbamat

M: CNS

anat (n/s/m/p/4/e/b/d/c/a/f/l/g)/phys/devp

noco (m/d/e/h/v/s)/cong/tumr, sysi/epon, injr

proc, lek (N1A/2AB/C/3/4/7A/B/C/D)